3 results match your criteria: "National Hospital Organization (NHO) Nagoya Medical Center[Affiliation]"
Neuroendocrine neoplasms of the breast: diagnostic confusion and future perspectives.
Virchows Arch
May 2023
Comprehensive Cancer Center, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Neuroendocrine tumor of the breast showing invasive micropapillary features and multiple lymph node metastases.
Cancer Rep (Hoboken)
February 2023
Department of Diagnostic Pathology, NHO Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
Article Synopsis
- A 65-year-old woman presented with a large tumor in her right breast, diagnosed as a mixed invasive micropapillary and neuroendocrine mammary neoplasm after a mastectomy.
- The tumor, characterized by a complex structure and significant hemorrhage, showed distinctive features on histopathology, including a vascular network and cancer cell nests surrounded by empty spaces.
- The patient had multiple metastases in lymph nodes and the tumor displayed a luminal B-like immuno-profile, suggesting the need for careful clinical monitoring due to its rarity and complexity.
Multicenter phase II study of infusional 5-fluorouracil (5-FU), leucovorin, and oxaliplatin, plus biweekly cetuximab as first-line treatment in patients with metastatic colorectal cancer (CELINE trial).
Oncol Lett
February 2017
Department of Surgery, National Hospital Organization (NHO) Nagoya Medical Center, Nagoya, Aichi 460-0001, Japan.
Article Synopsis
- * Patients experienced a median progression-free survival of 13.8 months, with 21.7% able to undergo surgery for previously unresectable metastases.
- * The combination was found to be well tolerated without increasing toxicity, suggesting it offers a flexible and effective first-line treatment option for this type of cancer.